Anthocyanins: Pharmacology and Nutraceutical Importance

Therapeutic Efficacy of Anthocyanins in Metabolic Disorders

Author(s): Sanchit Dhankhar, Kakul Chaudhary, Rishabh Chalotra, Monika Saini, Sumeet Gupta and Samrat Chauhan * .

Pp: 117-136 (20)

DOI: 10.2174/9789815223880124010010

* (Excluding Mailing and Handling)

Abstract

Metabolic syndrome (MetS) is a chronic disorder developed with cumulative symptoms of diabetes mellitus, hypertension and dyslipidemia. The etiologic causes of metabolic syndrome are a sedentary lifestyle, poor dietary choices, and hereditary factors, which have a negative impact on the health of people by increasing the risk of cardiovascular problems, organ damage, and additional pathology related to MetS. Anthocyanins (ANTs) are plant-based biomolecules that promote health and belong to a polyphenols subclass of flavonoids. Concurrent research reports have found that plants rich in ANTs may have therapeutic advantages for diabetes, obesity and MetS by decreasing insulin resistance, poor glucose resistance, dyslipidemia, high cholesterol levels in serum, hypertension, and inhibiting free radical formation. This chapter reviews the therapeutic advantage of ANTs in the management of MetS, along with their pharmacological mechanisms and biopharmaceutical functions. Similarly, the use of ANT-rich supplements is discussed for their potential in the control of MetS.

Related Journals
Related Books
© 2024 Bentham Science Publishers | Privacy Policy